Suchergebnisse - "Castagna, Luca"

PubPharm (11)

1

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia : a study from the ALWP of the EBMT

enthalten in: Bone marrow transplantation | 2022

von Devillier, R. | Galimard, J. | Labopin, M. | +24

2

Feasibility and Efficacy of a Pharmacokinetics-Guided Busulfan Conditioning Regimen for Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Adult Patients with Hematologic Malignancies

enthalten in: Transplantation and cellular therapy | 2021

von Bramanti, S. | De Philippis, C. | Bartoli, A. | +9

3

Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis : A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

enthalten in: American journal of hematology | 2021

von Polverelli, N. | Mauff, K. | Kröger, N. | +26

CommentIn: Am J Hematol. 2021 Jan;96(1):12-13. - PMID 33219701

4

Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission : A Report From the EBMT Acute Leukemia Working Party

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von El-Cheikh, J. | Labopin, M. | Al-Chami, F. | +12

5

The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m(2) intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia

enthalten in: Leukemia & lymphoma | 2016

von Wanquet, A. | Crocchiolo, R. | Furst, S. | +12

6

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen

enthalten in: Leukemia & lymphoma | 2014

von Saillard, C. | Crocchiolo, R. | Furst, S. | +9

7

Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2014

von Devillier, R. | Fürst, S. | El-Cheikh, J. | +16

8

A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor

enthalten in: American journal of hematology | 2014

von Devillier, R. | Fürst, S. | Crocchiolo, R. | +16

9

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases

enthalten in: Cancer | 2013

von Crocchiolo, R. | Esterni, B. | Castagna, L. | +10

10

Do different conditioning regimens really make a difference?

enthalten in: Hematology. American Society of Hematology. Education Program | 2012

von Blaise, D. | Castagna, L.